NAPPSA Knowledge Network
NAPPSA Intelligence Center 2.0
A pharmacist-first digital newsroom for clinical practice, community and hospital pharmacy, regulation, pharmaceutical science, global health, technology, workforce, and NAPPSA knowledge.
FDA authorizes the first wearable that tracks ketones and glucose together
On August 25, 2026 the FDA granted marketing authorization to Abbott Diabetes Care for the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, for people aged 2 years and older living with diabetes. It is the first wearable in the United States to monitor ketone levels continuously, and the first anywhere to read ketones and glucose from a single device.
- Measures ketones and glucose in the fluid just beneath the skin every minute, day and night, and sends readings wirelessly to a compatible smartphone with trend direction.
- Issues automatic alerts when ketone levels reach a concerning threshold, supporting earlier recognition of diabetic ketoacidosis before it becomes an emergency.
- Cleared through the De Novo premarket pathway with special controls, following a Breakthrough Device designation.
- Supported by six clinical studies enrolling more than 600 participants aged 2 years and older across a 10-day wear period.
Why it matters for pharmacists: ketone results are meant to be interpreted alongside glucose readings and symptoms, never in isolation. Expect counseling questions on sick-day rules, insulin pump and infusion-set failure, pediatric use from age two, and ketoacidosis risk in patients whose glucose still reads close to normal.
Top Stories
Breaking regulatory, clinical, and pharmaceutical developments
Explore pharmacy and healthcare news through the topic sections below.
Pharmacy Practice News
Community, hospital, specialty, ambulatory, and managed-care practice
Community & Retail Pharmacy
American Pharmacists Month: How Technology Breeds Sustainable Pharmacy Practice - Drug Topics
via Newsroom · Oct 20, 2026Why We Celebrate American Pharmacists Month - Drug Topics
via Newsroom · Oct 20, 2026Penn Highlands Community Pharmacy - DuBois marks 10 years of trusted care - The Courier Express
via Newsroom · Oct 20, 2026The profession of pharmacist is in crisis; only 48 per cent of pharmacy graduates choose it - Il Sole 24 ORE
via Newsroom · Oct 20, 2026
Hospital & Health-System Pharmacy
Moses Taylor Hospital Pharmacy Reopens in Scranton, PA - Hoodline
via Newsroom · Oct 20, 2026NCH starts 'meds to beds' program after hospital stay. How it helps - Naples Daily News
via Newsroom · Oct 20, 2026Use of potentially teratogenic medicines among hospitalised pregnant women identified - Hospital Pharmacy Europe
via Newsroom · Oct 20, 2026Local hospital opens retail pharmacy - Yahoo
via Newsroom · Oct 19, 2026
Specialty, Infusion & Ambulatory Care
SenderraRx Earns ACHC Reaccreditation in Specialty Pharmacy and Oncology Distinction - Pharmacy Practice News
via Pharmacy Practice News · Oct 16, 2026AI in Patient Care Helps but Requires Clinician Review - Specialty Pharmacy Continuum
via Newsroom · Oct 16, 2026Digital Supply Chain Pilot Targets Oncology Drug Shortages - Pharmacy Practice News
via Pharmacy Practice News · Oct 16, 2026Main Street Pharmacy Access Act Revives Push To Pay Pharmacists Under Medicare - Specialty Pharmacy Continuum
via Newsroom · Oct 14, 2026
Managed Care, PBMs & Reimbursement
PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026 - Drug Topics
via Newsroom · Oct 19, 2026PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026 - Drug Topics
via Newsroom · Oct 18, 2026The Coding Gap Nobody Prices In: Why New Specialty Drugs Launch Reimbursement-Blind - Pharmacy Times
via Pharmacy Times · Oct 8, 2026Your pharmacy benefit manager may not be working for you - Human Resources Director
via Newsroom · Oct 6, 2026
Clinical Intelligence
Point-of-care tools and evidence resources
Pharmacy Law, Policy & Compliance
Federal, state-board, controlled-substance, and legislative developments
Pharmacy Law News
OVERVIEW SHORT-TERM RECOMMENDATIONS POLICY SOLUTIONS TO ADDRESS THE DRUG SHORTAGE CRISIS - ASHP
via ASHP · Oct 17, 2026Student Pharmacists Reflect on the Power of Their Voice During ASHP Policy Week - ASHP NewsCenter
via ASHP · Oct 16, 2026Policy Recommendations for the March Virtual ASHP House of Delegates - ASHP
via ASHP · Oct 16, 2026ASHP Online Advertising Policy - ASHP
via ASHP · Oct 15, 2026
Direct Legal Reference
Search official federal, state-board, and Nigerian pharmacy-law sources by jurisdiction and practice topic.
Pharmaceutical Science & Industry
Research discoveries, manufacturing, biotechnology, approvals, and market intelligence
Industry & Trade Press (Fierce Pharma, PharmaTimes, The Pharma Letter, Pharmaceutical Technology)
Ambrose Healthcare fortifies rare disease pipeline on AM-Pharma takeover - Pharmaceutical Technology
via Pharmaceutical Technology · Oct 20, 2026EyePoint halves workforce and ends Phase III trial early after endpoint miss - Pharmaceutical Technology
via Pharmaceutical Technology · Oct 20, 2026Roche’s Enspryng nets a second indication on FDA eye disease approval - Pharmaceutical Technology
via Pharmaceutical Technology · Oct 19, 2026FDA approves Viatris’ Ryzumvi for adult presbyopia - Pharmaceutical Technology
via Pharmaceutical Technology · Oct 19, 2026
Pharmaceutical Research Watch
Scientists uncover 3 key brain pathways linked to lasting depression relief
Researchers have uncovered three brain pathways linked to lasting improvements in people receiving deep brain stimulation for severe, treatment-resistant depression. They also discovered that patients who failed to improve after two years shared a striking…
via ScienceDaily · Oct 18, 2026Scientists tested 39 sweeteners and uncovered surprising gut effects
Scientists have discovered that many common sweeteners can interfere with gut bacteria, with some combinations involving medications producing surprisingly strong effects. One sweetener mixed with a widely prescribed antidepressant reduced beneficial bacteria and microbial diversity…
via ScienceDaily · Oct 18, 2026New drug reverses severe fatty liver disease by repairing the gut
Scientists have discovered that a potential new drug can reverse severe fatty liver disease in animal models by restoring gut health and blocking harmful substances from reaching the liver. The breakthrough could pave the way…
via ScienceDaily · Oct 17, 2026
Pharmacy Technology & AI
Automation, informatics, robotics, digital health, cybersecurity, and artificial intelligence
Digital Pharmacy Intelligence
American Pharmacists Month: How Technology Breeds Sustainable Pharmacy Practice - Drug Topics
via Drug Topics · Oct 20, 2026Digital Experience Crucial for Pharmacies to Drive Patient Retention - Drug Topics
via Drug Topics · Oct 18, 2026Q&A: Why Rural Pharmacies Prioritize Trust Over Technology - Drug Topics
via Drug Topics · Sep 30, 2026Patient First, Powered by Al and Technology: Building Capacity for Patient Care - Drug Topics
via Drug Topics · Sep 29, 2026
Medication Safety Innovation
FDA Compounding Panel Backs 6 of 7 Peptides Despite Safety Risks in Oversight and Production - Pharmacy Practice News
via Pharmacy Practice News · Oct 20, 2026Research report: Reconfiguring clinical pharmacists’ roles under - Bioengineer.org
via Newsroom · Oct 20, 2026Beyond the Recall Notice: Why Pharmacies Need Greater Visibility Into Recalled and Expired Medications - Fierce Healthcare
via Newsroom · Oct 20, 2026Smart Pump–EHR Interoperability: Big Promise, Thin Evidence to Date - Pharmacy Practice News
via Pharmacy Practice News · Oct 19, 2026
Workforce, Education & Careers
Pharmacists, technicians, residency, fellowship, leadership, and academia
Pharmacy Workforce Intelligence
School of Pharmacy welcomes three new faculty members - Binghamton University
via Newsroom · Oct 14, 2026Swisslog Healthcare Launches Postdoctoral Pharmacy Fellowship Program - Business Wire
via Newsroom · Oct 13, 2026Pharmacy residency program supported by ASHP Foundation award - Auburn University
via Newsroom · Oct 13, 2026Why Are We Still Debating Whether a Pharmacy Residency Is "Worth It?" - Pharmacy Times
via Newsroom · Oct 12, 2026
Global Health & Africa
WHO, Africa, Nigeria, vaccines, access, manufacturing, and medicines policy
WHO Updates
New WHO technical package to help countries improve health data for COVID-19 response and beyond
Today, as part of its commitment to strengthening health information systems and improving health[1], especially in the context of the COVID-19 pandemic, WHO announced a new approach to improving access to life-saving data: the SCORE…
via WHO · Oct 10, 2026
Africa & Nigeria
NAFDAC Seeks Partners for Local Vaccine Manufacturing in Nigeria - MSME Africa
via Newsroom · Oct 5, 2026NAFDAC Seeks Foreign Support To Restart Local Vaccine Production - Arise News
via Newsroom · Oct 5, 2026FG pushes local drug production, eyes African pharma market - Vanguard News
via Newsroom · Oct 3, 2026Kenya Moves to Tighten Medicine Regulation as Africa Seeks Stronger Drug Supply Chains - healthbusiness.co.ke
via Newsroom · Sep 29, 2026
NAPPSA Knowledge
Institutional memory, governance, conference resources, and scholarship
NAPPSA Digest
NAPPSA Flu Clinic at 20th Annual Conference Vaccinates 65 People in Denver
The flu clinic held as part of the CSR event at NAPPSA's 20th Annual Scientific Conference in Denver vaccinated 65 people.
via NAPPSA Digest · Oct 18, 2026NAPPSA Congratulates Dr. Nina Mezu-Nwaba on Receiving the 2026 African Cultural Night Award
Congratulations, Dr. Nina Mezu-Nwaba, on receiving the 2026 African Cultural Night Award! Dr. Nina Mezu-Nwaba was honored with the 2026 African Cultural Night Award at the African Cultural Night Awards Ceremony, held on September 25,…
via NAPPSA Digest · Sep 26, 2026NAPPSA Co-Founder Emmanuel C. Ezirim Featured in Conglomerate Magazine for Community-Centered Pharmacy Practice
NAPPSA congratulates Dr. Emmanuel C. Ezirim, RPh, a co-founder and seventh President of the Association, who is profiled in Conglomerate Magazine following his 2026 Global Lifetime Achievement Award from the Global Directory of Who’s Who.…
via NAPPSA Digest · Sep 14, 2026